Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Budget, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
To amend the Public Health Service Act to establish a program to develop innovative antimicrobial drugs targeting the most challenging pathogens and most threatening infections, and for other purposes.
Chamber: United States House of Representatives (The United States of America)
Sponsors
(5)
EL"CEarl L. "Buddy" Carter
Republican · Primary
SPScott Peters
Democrat · Primary
NLNicholas Langworthy
Republican · Primary
MLMike Levin
Democrat · Primary
MCMike Carey
Republican · Primary
Legislative Votes
No votes have been held on this legislation yet.